| Latest Shire Plc News Headlines | | Date | Time | Source | | | 11/23/2009 | 10:00AM | UKREG | Blocklisting - Interim Review
TIDMSHP
BLOCK LISTING SIX MONTHLY RETURN
November 23, 2009 - Shire plc (LSE: SHP, NASDAQ: SHPGY)
Name of applicant: Shire plc
Name of scheme: 1996 Executive Share Option Scheme
Period of return: From: 23 May 2009 To: 22 November 2009
Balance... More...>> |
| 11/12/2009 | 7:02AM | UKREG | PDMR Shareholding
TIDMSHP
PDMR Shareholding
November 12, 2009 - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company (the "Company"), announces that on November 2, 2009
the following Persons Discharging Managerial Responsibility were granted
options over American Depository Shares ("ADSs") in the... More...>> |
| 11/03/2009 | 10:00AM | UKREG | Director/PDMR Shareholding
TIDMSHP
Directors/PDMR Shareholding
November 3, 2009 - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company (the "Company"), announces that on November 2, 2009,
it was notified of the acquisition, on November 2, 2009, of American Depository
Shares ("ADSs") in the Company by Persons... More...>> |
| 11/02/2009 | 5:00AM | UKREG | New Shire Board member
TIDMSHP
New Shire Board member
Dublin, Ireland - November 2, 2009 - The Board of Directors of Shire plc (LSE:
SHP, NASDAQ: SHPGY) announces that Mr David Stout joined the Board as a Non
Executive Director with effect from 31 October 2009.
Mr Stout has extensive pharmaceutical experience. Most recently he was... More...>> |
| 11/02/2009 | 2:00AM | UKREG | Total Voting Rights
TIDMSHP
Total Voting Rights
November 2, 2009 - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, in accordance with DTR 5.6.1 of the FSA's Disclosure
and Transparency Rules, notifies the market of the following:
At close of business on October 30, 2009, Shire plc's issued... More...>> |
| 10/30/2009 | 8:00AM | UKREG | 3rd Quarter Results
TIDMSHP
Shire continues to deliver excellent growth from core products
October 30, 2009 - Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty
biopharmaceutical company, announces results for the three months to September
30, 2009.
Q3 2009 Financial Highlights... More...>> |
| 10/26/2009 | 3:00AM | UKREG | FDA confirms VYVANSE (R) NCE exclusivity
TIDMSHP
FDA Determines VYVANSE® was Properly Granted Five-Year Market Exclusivity
DUBLIN, IRELAND - October 26, 2009 - Shire plc (LSE: SHP, NASDAQ: SHPGY), the
global specialty biopharmaceutical company, announces that the Food and Drug
Administration (FDA), following a thorough administrative review of governing... More...>> |
| 10/22/2009 | 7:00AM | UKREG | Third quarter 2009 results date notification
TIDMSHP
Third quarter 2009 results date notification - October 30, 2009
October 22, 2009 - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, will announce third quarter 2009 earnings on Friday
October 30, 2009.
Results press release will be 12:00 GMT / 08:00 ET
issued... More...>> |
| 10/21/2009 | 7:00AM | UKREG | Shire Targets Q4 Filing of BLA for REPLAGAL with US FDA
TIDMSHP
Shire Targets Fourth Quarter Filing of BLA for REPLAGAL® for Fabry Disease with
U.S. FDA
Early access for Fabry patients available under treatment protocol and
emergency IND
Cambridge, Massachusetts, US -October 21, 2009 - Shire plc (LSE: SHP, NASDAQ:
SHPGY), the global specialty biopharmaceutical... More...>> |
| 10/15/2009 | 9:00AM | UKREG | Holding(s) in Company
TIDMSHP
Notification of major interests in shares
October 15, 2009 - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company
1. Identity of the issuer or the underlying issuer of existing shares to which
voting rights are attached:
Shire plc
2. Reason for the notification... More...>> |
| 10/01/2009 | 11:00AM | UKREG | Total Voting Rights
TIDMSHP
Total Voting Rights
October 1, 2009 - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, in accordance with DTR 5.6.1 of the FSA's Disclosure
and Transparency Rules, notifies the market of the following:
At close of business on September 30, 2009, Shire plc's issued... More...>> |
| 09/25/2009 | 12:20PM | UKREG | Director/PDMR Shareholding
TIDMSHP
Director/PDMR Shareholding
September 25, 2009 - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company (the "Company"), announces that on September 25,
2009, it was notified by Mr Matthew Emmens, Chairman of the Company, of the
exercise, on September 24, 2009, of an option... More...>> |
| 09/22/2009 | 12:53PM | UKREG | Director/PDMR Shareholding
TIDMSHP
Director/PDMR Shareholding
September 22, 2009 - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company (the "Company"), announces that on September 21,
2009, Ms Tatjana May, a Person Discharging Managerial Responsibility, was
granted the following options under the Shire... More...>> |
| 09/18/2009 | 9:45AM | UKREG | Director/PDMR Shareholding
TIDMSHP
Director/PDMR Shareholding
September 18, 2009 - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company (the "Company"), announces that on September 18,
2009, Ms Anita Graham, a Person Discharging Managerial Responsibility,
exercised an option over 44,568 Shire ordinary shares... More...>> |
| 09/08/2009 | 7:00AM | UKREG | Update on velaglucerase alfa
TIDMSHP
Update on velaglucerase alfa
Cambridge, MA, U.S. - September 8th, 2009 - Shire plc (LSE: SHP, NASDAQ:
SHPGY), the global specialty biopharmaceutical company, is committed to doing
everything possible to assist Gaucher patients and their physicians during the
imiglucerase supply shortage. Shire is pleased... More...>> |
| 09/04/2009 | 7:00AM | UKREG | Director/PDMR Shareholding
TIDMSHP
Director/PDMR Shareholding
September 4, 2009 - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company (the "Company"), announces that on September 3, 2009
it was notified by Mr Angus Russell, Chief Executive Officer of the Company, of
a sale on the same day of 17,219 Shire... More...>> |
| 09/03/2009 | 7:00AM | UKREG | Director/PDMR Shareholding
TIDMSHP
Director/PDMR Shareholding
September 3, 2009 - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company (the "Company"), announces that on September 2, 2009,
Ms Barbara Deptula, a Person Discharging Managerial Responsibility, exercised
an option over 110,000 Shire ordinary... More...>> |
| 09/03/2009 | 7:00AM | UKREG | Shire Announces FDA Approval of Once-Daily INTUNIV(TM)
TIDMSHP
Shire Announces FDA Approval of Once-Daily INTUNIVtm (guanfacine) Extended
Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to
17
INTUNIV, the first nonscheduled alpha-2A receptor agonist indicated for ADHD,
demonstrated improvement in a range of ADHD symptoms that can... More...>> |
| 09/01/2009 | 7:35AM | UKREG | Total Voting Rights
TIDMSHP
Total Voting Rights
September 1, 2009 - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, in accordance with DTR 5.6.1 of the FSA's Disclosure
and Transparency Rules, notifies the market of the following:
At close of business on August 28, 2009, Shire plc's issued... More...>> |
| 09/01/2009 | 7:00AM | UKREG | Elections for interim dividend
TIDMSHP
ELECTIONS FOR INTERIM DIVIDEND IN RESPECT OF THE SIX MONTHS TO JUNE 30, 2009
September 1, 2009 - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announced on August 5, 2009 an interim dividend of
2.147 US cents per Ordinary share payable on October 8, 2009 to shareholders... More...>> |
|